You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenocarcinoma of the bladder

Showing 1 - 25 of 5,916
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,

Not yet recruiting
  • Bladder Squamous Cell Carcinoma
  • +10 more
  • Biospecimen Collection
  • +5 more
  • Atlanta, Georgia
  • +3 more
Feb 20, 2023

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Adenocarcinoma of the Bladder, Squamous Cell Carcinoma of the Bladder, Testicular Germ Cell Tumors Trial run by the National

Not yet recruiting
  • Adenocarcinoma of the Bladder
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Bladder Adenocarcinoma, Bladder Mixed Adenocarcinoma, Bladder Squamous Cell Carcinoma Trial in Palo Alto (drug, procedure,

Active, not recruiting
  • Bladder Adenocarcinoma
  • +11 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Mar 25, 2022

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Investigate Rectal Mucus in Aero-Digestive Tract Cancer.

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Oricol Test
  • Exeter, United Kingdom
    Royal Devon & Exeter NHS Foundation Trust
Jan 24, 2023

Breast Carcinoma, Colorectal Adenocarcinoma, Bladder Carcinoma Trial run by the National Cancer Institute (NCI) (Recombinant

Recruiting
  • Breast Carcinoma
  • +2 more
  • Recombinant human IL-7-hyFc (NT-I7)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
Jan 3, 2023

Urothelial Bladder Cancer, Triple-negative Breast Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Tremelimumab

Active, not recruiting
Has Results
  • Urothelial Bladder Cancer
  • +2 more
  • Tremelimumab monotherapy
  • +2 more
  • San Francisco, California
  • +13 more
Jan 20, 2023

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Prostate Cancer, Prostate Adenocarcinoma, Radiation Toxicity Trial in Miami (Smart Water Bottle)

Recruiting
  • Prostate Cancer
  • +2 more
  • Smart Water Bottle
  • Miami, Florida
    University of Miami Lennar Medical Foundation
May 10, 2022

NSCLC, Non-Small Cell Lung Adenocarcinoma, Non-Small Cell Squamous Lung Cancer Trial in Grand Rapids, San Antonio, Fairfax

Recruiting
  • Non-small Cell Lung Cancer
  • +10 more
  • Grand Rapids, Michigan
  • +2 more
Apr 25, 2023

oncRNA Stratification of Cancer by Size and Stage

Not yet recruiting
  • Kidney Cancer
  • +32 more
  • Exai oncRNA blood test
  • (no location specified)
Apr 27, 2023

Non-Transitional Cell Carcinoma of the Urothelial Tract, Small Cell of the Bladder, Adenocarcinoma of the Bladder Trial in

Completed
Has Results
  • Non-Transitional Cell Carcinoma of the Urothelial Tract
  • +4 more
  • durvalumab and tremelimumab
  • Basking Ridge, New Jersey
  • +3 more
Nov 3, 2021

Bladder Cancer, Urethral Cancer, Urachal Cancer Trial in Houston (5-Fluorouracil (5-FU), Leucovorin, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • 5-Fluorouracil (5-FU)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 18, 2021

Esophageal Adenocarcinoma, Esophagus SCC, Cholangiocarcinoma Trial in Belgium, France (Abemaciclib)

Active, not recruiting
  • Esophageal Adenocarcinoma
  • +4 more
  • Antwerpen, Belgium
  • +10 more
May 27, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Atlanta, Johns Creek (drug, other, procedure)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Atlanta, Georgia
  • +3 more
Mar 9, 2023

Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

Recruiting
  • Solid Tumor
  • +15 more
  • RAPA-201 Rapamycin Resistant T Cells
  • Chemotherapy Prior to RAPA-201 Therapy
  • Hackensack, New Jersey
    Hackensack University Medical Center
Dec 23, 2021

Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +14 more
  • Stereotactic body radiotherapy
  • Lattice Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2023

Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

Recruiting
  • Genitourinary Cancer
  • +7 more
  • La Jolla, California
  • +5 more
Jul 5, 2022

Urothelial Bladder Cancer, Gastric Adenocarcinoma, Gastro-oesophageal Adenocarcinoma Trial (Dostarlimab, Niraparib)

Not yet recruiting
  • Urothelial Bladder Cancer
  • +6 more
  • (no location specified)
Feb 26, 2021

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)

Recruiting
  • Bladder Cancer
  • +9 more
  • CAdVEC
  • Houston, Texas
    Baylor St. Luke's Medical Center
Feb 17, 2022